These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14366341)

  • 1. [Trial therapy of tuberculosis with a thiocarbanilide derivative (1,3-bis(p-ethoxyphenyl)-2-thiourea)].
    ROSSINI G; FERRARI B; ROSTI P; CATTANEO P; PIAZZA G
    G Ital Della Tuberc; 1954; 8(6):321-3. PubMed ID: 14366341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a diphenyl-thiourea (4-butyoxy-4'-dimethylamino-thiocarbanilide or Summit-1906) in certain types of leprosy].
    HARTER P; LITALIEN F; TRINH-THI-KIM-MONG-DON
    Bull Soc Pathol Exot Filiales; 1960; 53():950-60. PubMed ID: 13711914
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot study of the thiocarbanilide su-1906 in human pulmonary tuberculosis.
    JENKINS DE; JONES PO; YIN SC
    Am Rev Tuberc; 1956 Sep; 74(3):468-70. PubMed ID: 13354934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent observations on the vitamin E-type activity of 4-butoxy-4'-dimethylamino-thiocarbanilide (SU-1906)].
    BERGEL M
    Prensa Med Argent; 1958 Jul; 45(29):2565-6. PubMed ID: 13623678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trial therapy of leprosy with a diphenylthiourea derivative (Ciba 15095)].
    GATE J; ROUSSET J; COUDERT J
    Bull Soc Fr Dermatol Syphiligr; 1958; 65(2):164-5. PubMed ID: 13573068
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolism of arylthioureas. I. The metabolism of 1,3-diphenyl-2-thiourea (thiocarbanilide) and its derivatives.
    SMITH RL; WILLIAMS RT
    J Med Pharm Chem; 1961 Jul; 4():97-107. PubMed ID: 13914406
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro and in vivo study of the antituberculous activity of 4-4' diisoamyloxy-thiocarbanilide].
    TACQUET A; MACQUET V; BUU-HOI N; DAT-XUONG N
    Ann Inst Pasteur Lille; 1958-1959; 10():43-50. PubMed ID: 13980133
    [No Abstract]   [Full Text] [Related]  

  • 8. [1st trials with 4-4'-diisoamyloxy thiocarbanilide among the Congolese].
    FANIEL J
    Acta Tuberc Pneumol Belg; 1961; 52():237-40. PubMed ID: 13891531
    [No Abstract]   [Full Text] [Related]  

  • 9. N-D-aldopentofuranosyl-N'-[p-(isoamyloxy)phenyl]-thiourea derivatives: potential anti-TB therapeutic agents.
    Liav A; Angala SK; Brennan PJ; Jackson M
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2649-51. PubMed ID: 18362068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic effect of thiocarbanilide on 4,4' -dinitrocarbanilide, a component of nicarbazin.
    CUCKLER AC; POLIN D; PORTER CC
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):671-3. PubMed ID: 13431916
    [No Abstract]   [Full Text] [Related]  

  • 11. Rational design of 5'-thiourea-substituted alpha-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacterial growth.
    Van Daele I; Munier-Lehmann H; Froeyen M; Balzarini J; Van Calenbergh S
    J Med Chem; 2007 Nov; 50(22):5281-92. PubMed ID: 17910427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapeutic activity upon chromogenic mycobacteria of certain derivatives of thiocarbanilide (Su 1906), thiazoline (Su 3068), and thiazolidinone (Su 3912).
    MAYER RL; EISMAN PC; GISI TA; KONOPKA EA
    Am Rev Tuberc; 1958 Apr; 77(4):694-702. PubMed ID: 13521265
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the experimental bases of tuberculosis therapy with heavy metal preparation & newer chemotherapeutic drugs].
    VOMEL W
    Z Immun exp ther; 1958; 116(1-2):31-91. PubMed ID: 13593585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tuberculostatic activity of some p-sulfamidothiocarbanilides].
    DAT XUONG N
    C R Hebd Seances Acad Sci; 1955 Mar; 240(12):1378-80. PubMed ID: 14364917
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular actions of a bis-isothiourea.
    HENDERSHOT LC
    J Pharmacol Exp Ther; 1958 May; 123(1):1-8. PubMed ID: 13539782
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of leprosy with diphenyl thiourea compound SU 1906 (DPT); a report on expanded trials in Nigeria. I. A second report on the progress of the pilot trial with a review of the findings in expanded trials.
    DAVEY TF
    Lepr Rev; 1958 Jan; 29(1):25-44. PubMed ID: 13515392
    [No Abstract]   [Full Text] [Related]  

  • 17. Highly enantioselective direct conjugate addition of ketones to nitroalkenes promoted by a chiral primary amine-thiourea catalyst.
    Huang H; Jacobsen EN
    J Am Chem Soc; 2006 Jun; 128(22):7170-1. PubMed ID: 16734464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-enzymatic reduction of a 1,2,4-thiadiazolium derivative.
    Zhang F; Estavillo C; Mohler M; Cai J
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2172-8. PubMed ID: 18316189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antituberculosis activity in experimental animals of a group of substituted diphenyl-thioureas.
    EISMAN PC; KONOPKA EA; MAYER RL
    Tuberculol Thorac Dis; 1957 Mar; 16(3):154-7. PubMed ID: 13422643
    [No Abstract]   [Full Text] [Related]  

  • 20. Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity.
    Balzarini J; Van Daele I; Negri A; Solaroli N; Karlsson A; Liekens S; Gago F; Van Calenbergh S
    Mol Pharmacol; 2009 May; 75(5):1127-36. PubMed ID: 19233899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.